Associate ProfessorTracy Melzer

The pattern of neurotransmitter changes in Parkinson’s disease.

Claustrum Structure and its Role in Cognitive and Motor Decline in Parkinson’s Disease

Functional brain activation during the antisaccade task in Alzheimer’s disease

Ultra-High Contrast MRI in Parkinson’s disease: Mapping basal ganglia and deep white matter changes

Spatial coefficient of variance, arterial transit time, and blood flow

White matter integrity after gene therapy treatment of Ovine Batten Disease

Acquired stuttering in Parkinson’s disease: Exploring behavioural characteristics, response to treatment and brain changes associated with stuttering

Uncovering the mechanisms underlying acquired neurogenic stuttering by investigating changes in basal ganglia speech networks

Neuroplasticity following treatment in preschoolers who stutter.

Collisions in Junior Rugby

Hippocampal morphometry changes after limbic system lesions in primates

Evaluation of Neuroplastic Change Following Swallowing Skill Training

Imaging cerebral tau accumulation and cerebral blood flow in Parkinson’s disease

Parkinson’s disease: Longitudinal computerized cognitive testing

Speech changes in Parkinson’s disease: a neuroimaging and behavioural approach to disentangling motor and cognitive contributions.

Collisions in female junior rugby

Collisions in male junior rugby

MRI markers of cerebrovascular health in Parkinson’s disease

Structural connectivity in adults born with very low birthweight.

Accurate identification of white matter lesions in the brain.

Biomarkers for cognitive decline in Parkinson’s disease.

Early cannabis use and its impact on the aging brain: an MRI study of a New Zealand longitudinal birth cohort.

Brain biomarkers for future cognitive health in Parkinson’s.

Behavioural and neural correlates of treatment for developmental stuttering

Quantifying cerebrovascular health in Parkinson’s disease with MRI